Chronic Myeloid Leukemia (CML) is a type of cancer that begins in the blood-forming cells of the bone marrow and gradually spreads into the bloodstream. Unlike acute leukemias, which progress rapidly, CML develops slowly and often remains undetected in its early stages. Thanks to advances in medical science, early diagnosis and targeted therapies have significantly improved outcomes for patients with CML.